| Primary |
| Non-small Cell Lung Cancer |
27.6% |
| Breast Cancer |
19.5% |
| Lung Neoplasm Malignant |
11.1% |
| Breast Cancer Metastatic |
9.5% |
| Hodgkin's Disease |
4.8% |
| Lung Adenocarcinoma |
4.0% |
| Product Used For Unknown Indication |
4.0% |
| Drug Use For Unknown Indication |
3.9% |
| Breast Cancer Recurrent |
3.2% |
| Metastases To Central Nervous System |
1.6% |
| Ewing's Sarcoma |
1.5% |
| Prostate Cancer |
1.5% |
| Lung Squamous Cell Carcinoma Stage Unspecified |
1.3% |
| Diffuse Large B-cell Lymphoma |
1.2% |
| Lung Cancer Metastatic |
1.0% |
| Lung Carcinoma Cell Type Unspecified Stage Iv |
1.0% |
| Neoplasm Malignant |
0.9% |
| Chemotherapy |
0.8% |
| Rhabdomyosarcoma |
0.8% |
| Squamous Cell Carcinoma |
0.8% |
|
| Vomiting |
13.4% |
| Thrombocytopenia |
7.7% |
| Pulmonary Embolism |
6.2% |
| Sepsis |
6.2% |
| Pneumonia |
5.7% |
| Pyrexia |
5.7% |
| Renal Failure Acute |
5.7% |
| Respiratory Failure |
5.2% |
| Interstitial Lung Disease |
4.6% |
| Neutropenia |
4.6% |
| Septic Shock |
4.6% |
| White Blood Cell Count Increased |
4.6% |
| Febrile Neutropenia |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.6% |
| Pneumonitis |
3.1% |
| Transient Ischaemic Attack |
3.1% |
| Anaemia |
2.6% |
| Cardiac Failure |
2.6% |
| Dyspnoea |
2.6% |
|
| Secondary |
| Breast Cancer |
17.5% |
| Breast Cancer Metastatic |
14.3% |
| Drug Use For Unknown Indication |
13.0% |
| Product Used For Unknown Indication |
12.9% |
| Non-small Cell Lung Cancer |
8.3% |
| Lung Neoplasm Malignant |
5.0% |
| Hodgkin's Disease |
4.5% |
| Metastases To Central Nervous System |
3.5% |
| Sarcoma Metastatic |
3.5% |
| Ewing's Sarcoma |
3.0% |
| Breast Cancer Recurrent |
2.2% |
| Neoplasm Malignant |
2.1% |
| Hodgkin's Disease Stage Iv |
1.5% |
| Metastases To Bone |
1.5% |
| Lung Adenocarcinoma |
1.5% |
| Sarcoma |
1.4% |
| Premedication |
1.2% |
| Chemotherapy |
1.1% |
| Rhabdomyosarcoma |
1.0% |
| Metastases To Liver |
0.8% |
|
| Vomiting |
13.5% |
| Oxygen Saturation Decreased |
11.6% |
| Pyrexia |
9.7% |
| White Blood Cell Count Decreased |
8.8% |
| Neutropenia |
5.3% |
| Sepsis |
5.0% |
| Disease Progression |
4.1% |
| Febrile Neutropenia |
4.1% |
| Oral Candidiasis |
3.8% |
| Thrombocytopenia |
3.8% |
| Influenza |
3.4% |
| Renal Failure Acute |
3.4% |
| Mucosal Inflammation |
3.1% |
| Neuropathy Peripheral |
3.1% |
| Pancytopenia |
3.1% |
| Weight Decreased |
3.1% |
| Metastases To Liver |
2.8% |
| Respiratory Failure |
2.8% |
| Urinary Tract Infection |
2.8% |
| Osteonecrosis |
2.5% |
|
| Concomitant |
| Breast Cancer |
24.1% |
| Metastases To Bone |
18.6% |
| Breast Cancer Metastatic |
16.8% |
| Non-small Cell Lung Cancer |
4.8% |
| Pain |
4.8% |
| Drug Use For Unknown Indication |
4.8% |
| Product Used For Unknown Indication |
3.5% |
| Depression |
3.2% |
| Nausea |
2.1% |
| Breast Cancer Female |
2.0% |
| Hypercalcaemia |
2.0% |
| Prophylaxis Of Nausea And Vomiting |
1.8% |
| Muscle Spasms |
1.7% |
| Chemotherapy |
1.6% |
| Lung Neoplasm Malignant |
1.5% |
| Anaemia |
1.4% |
| Arthritis |
1.4% |
| Ovarian Cancer |
1.4% |
| Osteoporosis |
1.3% |
| Hypertension |
1.3% |
|
| Weight Decreased |
16.9% |
| Tooth Extraction |
13.7% |
| Vomiting |
10.0% |
| Toothache |
5.8% |
| White Blood Cell Count Decreased |
5.6% |
| Osteonecrosis |
5.3% |
| Disease Progression |
4.6% |
| Weight Increased |
4.2% |
| Death |
3.9% |
| White Blood Cell Count Increased |
3.6% |
| Pyrexia |
3.2% |
| Osteonecrosis Of Jaw |
3.1% |
| Wound Infection Staphylococcal |
3.1% |
| Pain |
2.5% |
| Walking Aid User |
2.5% |
| Wound Treatment |
2.5% |
| Neoplasm Malignant |
2.4% |
| Wheezing |
2.4% |
| Wound Debridement |
2.4% |
| Wound Drainage |
2.4% |
|
| Interacting |
| Hiv Infection |
40.0% |
| Product Used For Unknown Indication |
30.0% |
| Metastasis |
13.3% |
| Drug Use For Unknown Indication |
6.7% |
| Chronic Myeloid Leukaemia |
3.3% |
| Depression |
3.3% |
| Oral Fungal Infection |
3.3% |
|
| Pyrexia |
71.4% |
| Pancytopenia |
14.3% |
| Thrombocytopenia |
14.3% |
|
